Please login to the form below

Not currently logged in
Email:
Password:

Patient adherence co gains £10m investment

Atlantis Healthcare, the patient adherence organisation, has received a £10m investment from White Cloud Capital enabling further expansion

Atlantis Healthcare, a UK-based company that develops and manages health psychology, marketing and communications programmes to ensure patients adhere to their treatment regimes, has received a £10m investment from international investment company White Cloud Capital. The investment will allow Atlantis, which operates in nine countries, to expand further into Europe, Asia and the Middle East, as well as to extend its service offering and R&D capabilities.

The expansion comes at a time of growth in the incidence of chronic conditions, such as diabetes, which coincides with the increasing importance of patient adherence. 

"Our initiatives match the increasing emphasis being placed on actual patient outcomes as a basis for healthcare funding, as opposed to the traditional model of funding according to patient numbers," said Kate Reid, Atlantis UK general manager. "Across Europe and the UK, governments are looking to ensure the treatments they fund can be guaranteed to improve population health in a cost-effective way. That means developing innovative ways of working — especially in the primary care pathways — and that's exactly what we are doing."

With 45 patient programmes operational worldwide, Atlantis Healthcare is already established internationally, with customers including Pfizer, Novartis and the New Zealand Ministry of Health. Its Australian division has been the recipient of two PRIME Customer Focus awards and an Australian Direct Marketing Association (ADMA) Effectiveness Award.

20th July 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics